Metsera, Inc. (NASDAQ:MTSR - Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $21.18, but opened at $22.01. Metsera shares last traded at $19.15, with a volume of 122,076 shares changing hands.
Wall Street Analyst Weigh In
MTSR has been the topic of a number of research reports. Guggenheim began coverage on shares of Metsera in a research note on Tuesday, February 25th. They issued a "buy" rating and a $56.00 price target on the stock. Cantor Fitzgerald assumed coverage on Metsera in a report on Tuesday, February 25th. They set an "overweight" rating for the company. Bank of America started coverage on shares of Metsera in a report on Tuesday, February 25th. They issued a "buy" rating and a $38.00 price objective on the stock. Finally, Evercore ISI assumed coverage on Metsera in a research note on Tuesday, February 25th. They set an "outperform" rating on the stock.
Check Out Our Latest Research Report on Metsera
Metsera Price Performance
The business's fifty day simple moving average is $23.57.
Metsera (NASDAQ:MTSR - Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported ($3.52) EPS for the quarter.
About Metsera
(
Get Free Report)
Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
See Also
Before you consider Metsera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Metsera wasn't on the list.
While Metsera currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
